Clinical Evidence

Epygon, the developer of a new generation of transcatheter mitral valve has participated at PCR London Valve 2017, where the first presentation of its device has been made during Innovators Day. Our Chief Medical Officer, Marcio Scorsin, explained in details how we can deal with patients with high mitral regurgitation. The aim of Epygon project [...] Read more